← Human Trials & Peer-Reviewed Studies
Nutritional and hormonal effects of biosynthetic human growth hormone in surgical patients on total parenteral nutrition.
Plain-language guide to PMID 1802206 (1992): parallel-group controlled clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 30 patients.
Key Facts
- PMID
- 1802206
- Journal
- Nutrition (Burbank, Los Angeles County, Calif.)
- Year
- 1992
- Study type
- Controlled Clinical Trial
- Authors
- Piccolboni D et al. (8 authors)
What This Study Did, in Plain Language
What Was Tested
Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this controlled clinical trial publication.
The anabolic effects of biosynthetic human growth hormone (BHGH) were tested on 30 patients, aged 37-68 yr, divided into four groups: group 1 received surgery plus total parenteral nutrition (TPN) plus BHGH, group 2 received just surgery and TPN, Group 3 received TPN and BHGH, and group 4 received just TPN.
Who Took Part
The study group was 30 patients.
By PubMed's age tags, the people studied were adults, middle-aged adults and older adults.
How the Study Was Run
The design is described as placebo-controlled and parallel-group.
A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.
Groups ran in parallel: each of the patients stayed in one arm throughout.
Urinary creatinine loss was evaluated on days 3, 7, and 10.
What Was Measured
The anabolic effects of biosynthetic human growth hormone (BHGH) were tested on 30 patients, aged 37-68 yr, divided into four groups: group 1 received surgery plus total parenteral nutrition (TPN) plus BHGH, group 2 received just surgery and TPN, Group 3 received TPN and BHGH, and group 4 received just TPN.
PubMed files the paper under topics including Apolipoproteins B, Blood Glucose, Creatinine, Gastrointestinal Diseases, Growth Hormone, Hormones and Nitrogen.
What This Means in Plain Language
The paper is a placebo-controlled and parallel-group study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 30 patients.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 1992 (Nutrition (Burbank, Los Angeles County, Calif.)), a journal based in United States.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.